Employees buying VMD in their IRAs must be wonderingTheir IRA investment is down almost 60% in the last 12 months but see that senior managers have taken time to award themselves with generous stock options.
If the share price recovers its losses, the employee's IRAs may get their money back but the senior managers will make handsome profits. That has got to be demotivating!
On Feb 4, 2019, they released preliminary annual results. On April 6, 2020, they raised guidance and released preliminary results for Q1. It doesn't look like they have such intentions of providing an update notwithstanding the worst pandemic surge in our lifetimes.
Of the 8500+ stocks trading above $3 US, VMD's 12 month share performance falls below the 8 percentile mark.
Of the 3000+ stocks trading above $3 US and expecting to make a profit, its 12 month share performance falls below the 4 percentile mark.
VMD's investor relations can surely do better than this?
For years we had suggestions that VMD would buy out suffering competitors. They stated that they would rather make a big purchase rather than a small Mom and Pop shop purchases. They suggested that their competitors were suffering from the Phillips recall making it an acquisition opportunity. But then they felt they could just pick up patients that competitors could not serve. Well, we will see in a few weeks whether they are just saying things to fill the space at their CCs.
The holdings of institutional investors will happen in the next few days so we will see those results.